论文部分内容阅读
目的:探讨依达拉奉联合神经节苷脂对脑梗死患者神经功能缺损症状和生活能力的影响。方法:对本院神经外科2014年1月至2015年12月收治120例脑梗死患者临床治疗资料进行回顾性分析,随机将其分为对照组和观察组,对照组接受常规治疗,观察组在此基础上接受依达拉奉联合神经节苷脂治疗,比较分析两组患者的临床治疗效果。结果:观察组患者治疗总有效率85%,对照组治疗总有效率65%,两组对比,差异具有统计学意义(P<0.05)。观察组患者治疗1周、2周后神经功能缺损评分(NIHSS)和日常生活活动能力(ADL)评分结果均明显优于对照组,差异具有统计学意义(P<0.05)。结论:脑梗死患者接受依达拉奉联合神经节苷脂治疗,有助于提高其生活能力,以及改善神经功能缺损症状。
Objective: To investigate the effect of edaravone combined with ganglioside on neurological deficits and viability in patients with cerebral infarction. Methods: The clinical data of 120 patients with cerebral infarction admitted from January 2014 to December 2015 in our department of neurosurgery were retrospectively analyzed. The patients were randomly divided into control group and observation group. The control group received routine treatment. The observation group On the basis of edaravone combined ganglioside treatment, comparative analysis of two groups of patients with clinical treatment. Results: The total effective rate was 85% in the observation group and 65% in the control group. The difference between the two groups was statistically significant (P <0.05). The scores of NIHSS and ADL in the observation group were significantly better than those in the control group after 1 week and 2 weeks of treatment, the difference was statistically significant (P <0.05). CONCLUSIONS: Edaravone combined with gangliosides in patients with cerebral infarction is helpful to improve their viability and to improve symptoms of neurological deficits.